Skip to content
10-Q

Quarterly Report

PERSPECTIVE THERAPEUTICS, INC. CATX

0001193125-25-274328

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 74.34M sh
Shares Diluted Q3 2025 · Sep 30, 2025 74.3M sh
Shares Diluted Q3 2025 · Sep 30, 2025 73.64M sh
Shares Diluted Q3 2025 · Sep 30, 2024 70.63M sh
Shares Diluted Q3 2025 · Sep 30, 2024 62.29M sh
Capex Q3 2025 · Sep 30, 2025 $7.67M
Capex Q3 2025 · Sep 30, 2024 $39.8M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$57.83M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $8.31M
Long Term Debt Q3 2025 · Sep 30, 2025 $1.64M
Short Term Investments Q3 2025 · Sep 30, 2025 $147.38M
Short Term Investments Q3 2025 · Dec 31, 2024 $165.34M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $26.76M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $61.58M
Stockholders Equity Q3 2025 · Sep 30, 2025 $242.22M
Stockholders Equity Q3 2025 · Jun 30, 2025 $265.69M
Stockholders Equity Q3 2025 · Mar 31, 2025 $284.65M
Stockholders Equity Q3 2025 · Dec 31, 2024 $290.67M
Stockholders Equity Q3 2025 · Sep 30, 2024 $328.47M
Stockholders Equity Q3 2025 · Jun 30, 2024 $341M
Stockholders Equity Q3 2025 · Mar 31, 2024 $229.89M
Stockholders Equity Q3 2025 · Dec 31, 2023 $75.18M
Current Liabilities Q3 2025 · Sep 30, 2025 $20.62M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.23M
Total Liabilities Q3 2025 · Sep 30, 2025 $52.61M
Total Liabilities Q3 2025 · Dec 31, 2024 $50.43M
Current Assets Q3 2025 · Sep 30, 2025 $178.5M
Current Assets Q3 2025 · Dec 31, 2024 $231.16M
Total Assets Q3 2025 · Sep 30, 2025 $294.83M
Total Assets Q3 2025 · Dec 31, 2024 $341.1M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.89
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.21
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.62
Eps Basic Q3 2025 · Sep 30, 2025 −$0.35
Eps Basic Q3 2025 · Sep 30, 2025 −$0.89
Eps Basic Q3 2025 · Sep 30, 2024 −$0.21
Eps Basic Q3 2025 · Sep 30, 2024 −$0.62
Sga Expense Q3 2025 · Sep 30, 2025 $7.73M
Sga Expense Q3 2025 · Sep 30, 2025 $23.28M
Sga Expense Q3 2025 · Sep 30, 2024 $6.98M
Sga Expense Q3 2025 · Sep 30, 2024 $18.37M
Rd Expense Q3 2025 · Sep 30, 2025 $20.34M
Rd Expense Q3 2025 · Sep 30, 2025 $51.29M
Rd Expense Q3 2025 · Sep 30, 2024 $12.03M
Rd Expense Q3 2025 · Sep 30, 2024 $28.76M
Net Income Q3 2025 · Sep 30, 2025 −$25.97M
Net Income Q3 2025 · Sep 30, 2025 −$65.63M
Net Income Q3 2025 · Jun 30, 2025 −$21.49M
Net Income Q3 2025 · Mar 31, 2025 −$18.18M
Net Income Q3 2025 · Sep 30, 2024 −$15.12M
Net Income Q3 2025 · Sep 30, 2024 −$39.11M
Net Income Q3 2025 · Jun 30, 2024 −$11.7M
Net Income Q3 2025 · Mar 31, 2024 −$12.28M
Operating Income Q3 2025 · Sep 30, 2025 −$27.86M
Operating Income Q3 2025 · Sep 30, 2025 −$73.73M
Operating Income Q3 2025 · Sep 30, 2024 −$18.63M
Operating Income Q3 2025 · Sep 30, 2024 −$45.9M